This CPB is revised to state that von Willebrand factor/coagulation factor VIII complex (Wilate) is considered medically necessary for prevention of excessive bleeding during and after minor and major surgery in persons with VWD. This CPB is revised to state that recombinant factor VIII (Nuwiq) is considered medically necessary to prevent or treat hemorrhagic complications in adults and children with hemophilia A when criteria are met.